Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models.

about

Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors.New targets and therapies for gastrointestinal stromal tumors.

P2860

Q36498218-E320F0C7-6B9E-45BB-964B-81DB197A1F45 Q47140976-4450E06F-C4A9-409C-963B-AE05FDCE86A1 Q47432725-778158BB-953B-44BB-8057-BB6B9AAF9418

P2860

Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models.

Item

http://www.wikidata.org/entity/Q35555471

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Therapeutic Efficacy Assessmen ...... tromal Tumor Xenograft Models.

@ast

Therapeutic Efficacy Assessmen ...... tromal Tumor Xenograft Models.

@en

type

Item

label

Therapeutic Efficacy Assessmen ...... tromal Tumor Xenograft Models.

@ast

Therapeutic Efficacy Assessmen ...... tromal Tumor Xenograft Models.

@en

prefLabel

Therapeutic Efficacy Assessmen ...... tromal Tumor Xenograft Models.

@ast

Therapeutic Efficacy Assessmen ...... tromal Tumor Xenograft Models.

@en

P1476

Therapeutic Efficacy Assessmen ...... tromal Tumor Xenograft Models.

@en

P2093

Haifu Li

http://www.w3.org/2001/XMLSchema#string

Thomas Van Looy

http://www.w3.org/2001/XMLSchema#string

Ulla Vanleeuw

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of a c-kit product complex reveals the basis for kinase transactivation

KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

A potent combination of the novel PI3K Inhibitor, GDC-0941, with imatinib in gastrointestinal stromal tumor xenografts: long-lasting responses after treatment withdrawal.

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis

A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth.

P304

112-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TRANON.2015.02.004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275466612

http://www.w3.org/2001/XMLSchema#string

P698

25926077

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

4415139

http://www.w3.org/2001/XMLSchema#string

Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models.

about

P2860

P2860

Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932